It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Brantly asked that Writebol be given the first dose because he was younger and he thought he had a better chance of fighting it, and she agreed. However, as the first vial was still thawing, Brantly's condition took a sudden turn for the worse. Brantly began to deteriorate and developed labored breathing. He told his doctors he thought he was dying, according to a source with firsthand knowledge of the situation.
Knowing his dose was still frozen, Brantly asked if he could have Writebol's now-thawed medication. It was brought to his room and administered through an IV. Within an hour of receiving the medication, Brantly's condition dramatically improved. He began breathing easier; the rash over his trunk faded away. One of his doctors described the events as "miraculous."
originally posted by: loam
a reply to: Staroth
Exactly.
According to a CDC spokesperson testing for Ebola takes 1-2 days after they receive the samples. The primary testing is PCR. This is performed on blood that has been treated to kill and live virus. So far CDC has tested samples from around 6 people who had symptoms consistent with Ebola and a travel history to the affected region.
Link.
But the UK announced almost immediately that she was negative. Of course, no mention too that rapid tests commonly produce false negatives. Brantley, Sawyer, & Nshamdze all tested negative on their first tests.
originally posted by: DrHammondStoat
How commonly are these false negatives produced in these rapid tests?
originally posted by: loam
a reply to: kruphix
The news stories didn't just conflict, the SOURCE's story did. Do your research and read the quotes from Samaritan and the CDC.
Brantly and Writebol were aware of the risk of taking a new, little-understood treatment and gave informed consent, according to two sources familiar with the care of the missionary workers.
originally posted by: loam
a reply to: DrHammondStoat
originally posted by: DrHammondStoat
How commonly are these false negatives produced in these rapid tests?
I haven't been able to track down a precise answer yet, but....
Brantley initially tested negative.
Sawyer initially tested negative.
Nshamdze initially tested negative.
All three had Ebola.
False-Negative Results of PCR Assay with Plasma of Patients with Severe Viral Hemorrhagic Fever
hospital officials say, he was tested for both malaria and HIV AIDS. However, when both tests came back negative, he was then asked whether he had made contact with any person with the Ebola Virus, .........
...... Back in Lagos, authorities at the First Consultants Hospital in Obalende decided that despite Sawyer’s denial, they would test him for Ebola, due to the fact that he had just arrived from Liberia, where there has been an outbreak of the disease with more than 100 deaths. The hospital issued a statement this week stating that Sawyer was quarantined immediately after he was discovered to have been infected with the deadly virus.
originally posted by: loam
a reply to: DrHammondStoat
You need to start reading here.
Direct from the source.
Hope that explains it.
Meanwhile, a source familiar with details of the treatment said that three top secret, experimental vials stored at subzero temperatures were flown into Liberia last week in a last-ditch effort to save two American missionary workers who had contracted the virus.
Link.
originally posted by: DrHammondStoat
Again it comes down to interpretation by reporters.
originally posted by: loam
a reply to: DrHammondStoat
I'm assuming the field test is very unreliable at any stage. The PCR test described above is the one the CDC is using and takes two days.
So short answer is they all seem unreliable.
Currently there are no commercial kits for diagnosis of VHFs, but a number of different diagnostics are available at specialized laboratories. Nowadays, early diagnosis is mainly based on direct detection of viral antigens or RNA. In particular the United States Army Medical Research Institute of Infectious Diseases [9] (2010) and New York Columbia University [10,11] (2006) , have recently developed multiplex PCR assays for specific detection of multiple VHFs. Although field data are limited (available only for Lassa), these systems have been evaluated for the detection of a consistent number of different agents form viral cultures, such as Ebola, Marburg, Lassa, Machupo, Junin, Sabia, Guanarito, Andes and Sin Nombre.
The data presented here also illustrate the drawback of the reliance on any single diagnostic assay alone, including the RT-PCR assay, for EHF diagnosis. The most serious shortcoming of the RT-PCR assay is the greater ease with which false positives and false negatives can be generated.
A nested assay is especially prone to template contamination because there is the extra high-risk step of physically opening the first-round reactions, thus increasing the potential exposure to high concentrations of DNA amplicons. This risk may increase as the outbreak continues, as more and more positive samples are analyzed. In this outbreak, there were three PCR+ Ag− samples that by analysis of duplicate samples were later shown to be falsely positive by PCR. Most of the potentially false-positive samples occurred in the later stages of the outbreak.
The individuals from whom the 10 unresolved samples were taken were unavailable for subsequent sampling to verify or disprove the initial results. While a false positive can clearly put an individual at unnecessary risk by causing the person to be placed in a high-risk environment (e.g., an Ebola isolation ward), more serious consequences can occur from false negatives. With a false-negative result, a person may be released into the community with the understanding that they do not have EHF, when in fact they have the potential to become highly contagious and, at least initially, assume their symptoms are not due to EHF.
Because of the serious potential for false positives and negatives, we do not rely solely on a single diagnostic test but instead on a collection of tests that together establish a laboratory diagnosis. For instance, sole reliance on the first RT-PCR assay (using the Filo A and B primers) used in the beginning phase of the outbreak would have led to the initial misclassification of 19 of 46 samples. The false negatives could have resulted for a number of reasons, which include but are not limited to inhibitor contamination of the RNA preps, a low copy number of the target sequence (particularly in the first days after the onset of symptoms in nonfatal cases), and nucleotide mismatches between primer and target sequences that are a result of the unique genetic identity of the particular ebolavirus strain. In addition, the RNA extractions were performed under suboptimal conditions, as ice was not available and the ambient temperature was often ≥30°C. The first point, regarding inhibitor or protein contamination, can easily be dealt with in the laboratory by repurification of the sample and/or dilution of the RNA prior to analysis (10)
Of the 246 PCR-positive (PCR+) samples, 196 were concordant with the antigen-capture assay (i.e., PCR+ Ag+), leaving 50 samples that were discordant with the antigen-capture assay (PCR+ Ag−). Among the 50 discordant samples, 17 (representing 13 patients) were obtained very early in the acute phase of disease, just after the onset of symptoms but prior to testing positive by antigen capture (early detection) in subsequent samples. Another 20 PCR+ Ag− specimens (representing 18 patients) were obtained during the convalescent phase, coincident with IgM (data not shown) and/or IgG responses. These convalescent-phase patients often remained PCR positive for 24 to 48 h (the maximum interval was 72 h) after clearing detectable antigen.The remaining 13 discordant samples represented potential false positives, as determined by using the antigen-capture ELISA as the reference standard (assuming no antigen false positives) to which the RT-PCR assay was compared. Three of the potential false-positive samples were later proven to be PCR− Ag− by testing of duplicate samples from the same patient, and 10 were unresolvable due to the lack of additional confirmatory samples.
The antibody work came out of research projects funded more than a decade ago by the U.S. Army to develop treatments and vaccines against potential bio-warfare agents, such as the Ebola virus, Arntzen said in a telephone interview.
originally posted by: ~Lucidity
originally posted by: DrHammondStoat
Again it comes down to interpretation by reporters.
I have a few issues with this statement.
1. That dog don't hunt anymore.
2. Calling the reporters implying that they are journalists isn't flying anymore.
3. Irresponsible reporting is dangerous and so is being an apologist for it.
4. People who apply this rule to only what they want to believe are dangerous too.
5. All the more reason to keep questioning them and their "stories" and intentions.
If true, could the third have been intended for Sawyer?
a reply to: loam
If true, think the third vial could the third have been intended for Sawyer?
originally posted by: grantbeedSeems there are quite a few companies involved in this, and it seems it's been going on for quite a while too.
originally posted by: loam
a reply to: WanDash
Except the primary SOURCES for these stories is Samaritans and the CDC. The contradictions come from THEM.
THEY said one thing.....and then another completely different thing.